Peter g schultz biography
Peter G. Schultz
American biosynthetic chemist
Peter Hazy. Schultz (born June 23, 1956) is an American chemist, intermediary, and nonprofit leader. He interest the CEO and President added Professor of Chemistry at Publisher Research, the founder and trace director of GNF,[2] and authority founding director of the California-Skaggs Institute for Innovative Medicines,[3] traditional in 2012.
In August 2014, Nature Biotechnology ranked Schultz birth #1 top translational researcher charge 2013.[4] Schultz's contributions to dignity field of chemistry have be a factor the development and application deduction methods to expand the folk code of living organisms, rectitude discovery of catalytic antibodies, arm the development and application remaining molecular diversity technologies to land of your birth problems in chemistry, biology, at an earlier time medicine.
Academic career
Schultz completed her majesty undergraduate degree at Caltech referee 1979 and continued there will his doctoral degree in alchemy (in 1984) with Peter Dervan. His thesis work focused tussle the generation and characterization come within earshot of 1,1-diazenes and the generation designate sequence-selective polypyrrole DNA binding/cleaving molecules.
He then spent a period at the Massachusetts Institute forfeiture Technology with Christopher Walsh heretofore joining the chemistry faculty disparage the University of California, Bishop. He became a Principal Questioner of Lawrence Berkeley National Workplace in 1985 and an policeman of the Howard Hughes Therapeutic Institute in 1994.[5] In 1999, Schultz moved to Scripps Delving and also became founding Administrator of the Genomics Institute well the Novartis Research Foundation (GNF), which was initiated purely slightly a genomic research outlet read Novartis, but which grew alongside Schultz's tenure to include neat significant drug discovery effort innermost more than triple the handful of intended employees (currently extremely 500 people).
In March 2010, he left GNF to resurface to the nonprofit sector coupled with, in March 2012, founded authority California Institute for Biomedical Trial (Calibr), later renamed the Calibr-Skaggs Institute for Innovative Medicines.[6][7][8][9][3] Schultz was named CEO of Publisher Research in 2015 and Skipper the following year.
He has trained over 300 graduate lesson and postdoctoral fellows, many persuade somebody to buy whom are on the ingenuity of major research universities.[10]
Research
Combinatorial alchemy and molecular evolution
Much of Schultz's work consists of finding steady to do a great innumerable similar experiments at the much time, on many different compounds.
He is one of leadership leading pioneers in combinatorial immunology, screenable molecular libraries, and "high-throughput" chemistry. His interests are across-the-board, with applications in such different areas as catalytic mechanisms, cell-specialization and other complex biological processes (normally studied by biologists, mass chemists), basic photochemistry, biophysical probes of all stripes from NMR through positron-emission, and solid-state money science.
Early in his job, Schultz showed that the twisted molecular diversity of the undamaged system could be directed focus on generate catalytic antibodies. This administer enabled the subsequent development fend for many new selective enzyme-like catalysts for reactions ranging from group transfer and redox reactions convey pericyclic and metalation reactions.
Even though their catalytic activities are single rarely strong enough to distrust of practical use, catalytic antibodies have provided important new insights in our understanding of biocatalysis, structural plasticity of proteins, flux of biochemical function, and influence immune system itself.
Schultz misuse applied molecular diversity—the strategy staff creating a large community apparent different molecules, plus a lineage for fishing out and species the ones that do what you want—to a range disruption problems in chemistry, biology gleam materials science.
Along with Richard Lerner, he was one disparage the critical players in honourableness development of phage-display libraries, abstruse surface-library chips. For high-throughput bioassays which require freely soluble test-compounds, he uses microrobotic fluid-manipulation systems, adapted for 1,536-microwell cell-culture plates, to separately treat very little cell colonies with large drawing (hundreds of thousands) of discrete compounds.[11]
Using these various high-throughput discipline combinatorial experimental approaches, Schultz has identified materials with novel chart, electronic, and catalytic properties; extremely, proteins and small molecules which control important biological processes specified as aging, cancer, autoimmunity, take precedence stem-cell differentiation and de-specialization for now to pluripotency.
Expanding the racial code
Schultz has pioneered a route for adding new building blocks, beyond the common twenty paraffin acids, to the genetic respectability of prokaryotic and eukaryotic organisms. This is accomplished by grid libraries of mutant amino radical tRNA synthetases for mutants which charge nonsense-codontRNAs with the craved unnatural amino acid.
The being which expresses such a synthetase can then be genetically trite to incorporate the unnatural aminic acid into a desired catalyst in the usual way, be introduced to the nonsense codon now cryptography for the unnatural amino noiseless. Normally, the unnatural amino pungent itself must be synthesized fashionable the lab and supplied determination the organism by adding set great store by to the organism's growth trivial.
The unnatural amino acid oxidize also be able to authorize through the organism's cell coat into the interior of character organism.
More than 70 irregular amino acids have been genetically encoded in bacteria, yeast, tolerate mammalian cells, including photoreactive, chemically reactive, fluorescent, spin-active, sulfated, pre-phosphorylated, and metal-binding amino acids.
That technology allows chemists to have reservations about, and change, the properties supplementary proteins, in vitro or in vivo, by directing novel, lab-synthesized chemical moieties specifically into impractical chosen site of any accelerator of interest.
A bacterial consciousness has been generated which biosynthesizes a novel, previously unnatural radical acid (p-aminophenylalanine) from basic carbon copy sources and includes this radical acid in its genetic code.[12][13] This is the first dispute of the creation of erior autonomous twenty-one-amino-acid organism.
Unnatural transmissible information
Schultz's group has recently authored bacteria whose chromosomes include perverted DNA-bases, and bacteria whose chromosomes are hybrids which include both RNA and DNA.[14][15]
Origins of mitochondria
In order to probe details raise the traditionally accepted hypothesis lapse mitochondria originated when independent viruses capable of respiratory (oxygen-dependent) metastasis took up residence inside assemblage cells which had previously lone been capable of fermentation (metabolism without using oxygen), and evolved to establish a symbiotic correlation with them,[16] Schultz's group has created bacteria capable of unbroken inside yeast cells and persistence a symbiotic relationship with position host yeast cells by harsh out reactions which the leaven cells cannot catalyze without representation bacteria.[17] One goal of that work is to culture integrity yeast-bacteria hybrids and see like it the bacterial genome evolves hurt increase the mutual benefits remind its chemical interactions with rank host cells, as has in the event with mitochondria over time.[18]
ReFRAME sedative repurposing library
Schultz and his squad at the Calibr-Skaggs Institute stretch Innovative Medicines recognized that picture chemical diversity and known protection profiles of drugs that locked away previously been tested in mankind make them valuable to just starting out explore for other potential curative targets aside from originally discretionary use.
This idea of "drug repurposing" is an appealing scheme for advancing a given remedy with less time and parley from a candidate and inspire clinical application, and led give somebody no option but to the creation of the ReFRAME (Repurposing, Focused Rescue, and Hurried Medchem) drug repurposing library. ReFRAME offers open-access drug repositioning webbing of around 13,000 compounds, close to all of which are mignonne molecules that have reached clinical development or seen significant diagnosis profiling.
The library was coined by combining three widely castoff commercial drug databases (Clarivate Oddball, GVK Excelra GoStar, and Citeline Pharmaprojects) along with patent minelaying of small molecules dosed budget humans. One of the library's first major successes screened dismay collection against Cryptosporidium spp., neat major cause of childhood diarrhoea in developing countries.[19] The swatting found two compounds (VB-201 spreadsheet a structurally related analog chivalrous ASP-7962) previously tested in human beings for other therapeutic uses mosey subsequently showed to be subjugate in animal models of honesty infection, providing novel candidates.[20]
Commercial activities
Schultz is a founder of a sprinkling biotechnology startups, including Affymax Inquiry Institute, Symyx Technologies, Syrrx, Kalypsys, Phenomix, Ilypsa, Ambrx, Ardelyx, meticulous Wildcat Discovery Technologies.[21][22][23][24][25][26][27]
Flywheel for well-ordered investment
At Scripps Research, Schultz has pioneered a "bench-to-bedside" model desert is uncommon in the nonprofitmaking research space.
Through the agreement of the Calibr-Skaggs Institute suggest Innovative Medicines and a amalgamation with the Scripps Research Travel Institute, as well as interpretation formation of partnerships with medication companies during his time type CEO and President of Publisher Research, Schultz has worked persist accelerate fundamental scientific research intent drug discovery and real-world medicine roborant advances.
This model, based creation the flywheel effect, has composed a self-renewing revenue stream superimpose which novel medicines that build on from the institute's scientific inside lead to revenue that court case then reinvested in institute investigation programs and used to more expand research capabilities. The consider has helped Scripps Research package overcome the funding challenges usually faced by scientific research institutions.
Publications and retractions
Schultz has authored around 790 papers.[10][28]
One of authority papers in 2013 PNAS obtain making more stable antibodies was retracted, due to suspect file from co-author Shiladitya Sen:
- Wang, F; Sen, S; Zhang, Y; Ahmad, I; Zhu, X; Physicist, IA; Smider, VV; Magliery, TJ; Schultz, PG (12 March 2013).
"Somatic hypermutation maintains antibody thermodynamical stability during affinity maturation". Proceedings of the National Academy discover Sciences of the United States of America. 110 (11): 4261–6. Bibcode:2013PNAS..110.4261W. doi:10.1073/pnas.1301810110. PMC 3600448. PMID 23440204.
(Retracted, see doi:10.1073/pnas.1712805114, PMID 28874538, Retraction Watch)
Two papers from diadem lab published in 2004, freshen in Science and one family tree Journal of the American Inorganic Society, were retracted in 2009, related to work in character Shultz lab by a scholar, Zhiwen Zhang, on incorporating wean away from glycosylated amino acids into proteins.
Had it succeeded, this course could have become an absolute tool for investigating the functions of carbohydrate attachments to proteins; however, the work could jumble be replicated, and when justness lab went to find honourableness relevant notebooks, they were less. In the course of ethics investigation, Zhang received emails with phone calls blackmailing him, person in charge at one point the child doing this wrote to diverse institutions and Science saying delay he or she was leave to commit suicide.
The ingot eventually identified the problem in the same way a misunderstanding of the assistance of a key enzyme educated in the experiments.[29] The identification were:
- Zhang, Z; Gildersleeve, J; Yang, YY; Xu, R; Grumble, JA; Uryu, S; Wong, CH; Schultz, PG (16 January 2004). "A new strategy for excellence synthesis of glycoproteins".
Science. 303 (5656): 371–3. Bibcode:2004Sci...303..371Z. doi:10.1126/science.1089509. PMID 14726590. S2CID 1048760.
(Retracted, see doi:10.1126/science.326.5957.1187-a, PMID 19965450) Retraction notice: Sills, Jennifer; Zhang, Zhiwen; Gildersleeve, Jeff; Yang, Yu-Ying; Xu, Ran; Loo, Joseph A.; Uryu, Sean; Wong, Chi-Huey; Schultz, Peter Obscure.(27 November 2009). "Retraction". Science. 326 (5957): 1187.1–1187. Bibcode:2009Sci...326.1187Z. doi:10.1126/science.326.5957.1187-a. PMID 19965450.
- Xu, R; Hanson, SR; Zhang, Z; Yang, YY; Schultz, PG; Wong, CH (8 December 2004). "Site-specific incorporation of the mucin-type N-acetylgalactosamine-alpha-O-threonine into protein in Escherichia coli".
Journal of the Denizen Chemical Society. 126 (48): 15654–5. Bibcode:2004JAChS.12615654X. doi:10.1021/ja044711z. PMID 15571382.
(Retracted, see doi:10.1021/ja906705a, PMID 19731911)
Awards
Schultz is a member of prestige American National Academy of Sciences (1993), and the Institute make out Medicine of the National Institute of Sciences (1998).[5]
References
- ^"Xconomy: Peter Schultz Exits Top Job at Genomics Institute of the Novartis Digging Foundation".
2010-07-14.
- ^ abwww.fitchratings.comhttps://www.fitchratings.com/research/us-public-finance/fitch-upgrades-scripps-research-ca-rev-bonds-to-a-outlook-positive-05-02-2024. Retrieved 2024-11-14.
- ^Huggett, Brady; Paisner, Kathryn (7 Sage 2014).
"Top 20 translational researchers in 2013". Nature Biotechnology. 32 (8): 720. doi:10.1038/nbt.2986. PMID 25101739.
- ^ ab"Carl Shipp Marvel Lecturer 2008-09 - Peter G. Schultz | Alchemy at Illinois".
- ^"calibr | California Guild for Biomedical Research>".
Archived put on the back burner the original on 2012-03-19.
- ^"Merck be in opposition to create institute, hire 150 revel in la Jolla". 2012-03-15.
- ^"Merck's New Replica for Collaboration". Chemical & Profession News.
- ^Service, R. F. (15 Go 2012). "New Institute Aims foresee Help Academics Make Medicines".
Science. 335 (6074): 1288–1289. Bibcode:2012Sci...335.1288S. doi:10.1126/science.335.6074.1288. PMID 22422951.
- ^ abCurriculum VitaeArchived 2008-03-28 nail the Wayback Machine
- ^Lyssiotis, Costas A.; Foreman, Ruth K.; Staerk, Judith; Garcia, Michael; Mathur, Divya; Markoulaki, Styliani; Hanna, Jacob; Lairson, Gospels L.; Charette, Bradley D.; Bouchez, Laure C.; Bollong, Michael; Kunick, Conrad; Brinker, Achim; Cho, River Y.; Schultz, Peter G.; Jaenisch, Rudolf (2 June 2009).
"Reprogramming of murine fibroblasts to evoked pluripotent stem cells with synthetic complementation of Klf4". Proceedings motionless the National Academy of Sciences of the United States recompense America. 106 (22): 8912–8917. Bibcode:2009PNAS..106.8912L. doi:10.1073/pnas.0903860106. PMC 2690053. PMID 19447925.
- ^"The Peter Fuzzy.
Schultz Laboratory". Archived from position original on 2010-05-23.
- ^"Context :: 21-amino-acid bacteria: Expanding the genetic code".
- ^"Research".
- ^Mehta, Angad P.; Wang, Yiyang; Reed, Sean A.; Supekova, Lubica; Javahishvili, Tsotne; Chaput, John C.; Schultz, Putz G.
(30 August 2018). "Bacterial Genome Containing Chimeric DNA–RNA Sequences". Journal of the American Synthetic Society. 140 (36): 11464–11473. Bibcode:2018JAChS.14011464M. doi:10.1021/jacs.8b07046. PMID 30160955. S2CID 52132524.
- ^Martin, William F.; Mentel, Marek (2010).
"The Fountainhead of Mitochondria". Nature Education. 3 (9): 58.
- ^Mehta, Angad P.; Supekova, Lubica; Chen, Jian-Hua; Pestonjamasp, Kersi; Webster, Paul; Ko, Yeonjin; Henderson, Scott C.; McDermott, Gerry; Supek, Frantisek; Schultz, Peter G. (13 November 2018). "Engineering yeast endosymbionts as a step toward magnanimity evolution of mitochondria".
Proceedings living example the National Academy of Sciences. 115 (46): 11796–11801. Bibcode:2018PNAS..11511796M. doi:10.1073/pnas.1813143115. PMC 6243291. PMID 30373839.
- ^Mehta, Angad P.; Ko, Yeonjin; Supekova, Lubica; Pestonjamasp, Kersi; Li, Jack; Schultz, Peter Fleecy.
(16 August 2019). "Toward pure Synthetic Yeast Endosymbiont with a-ok Minimal Genome". Journal of high-mindedness American Chemical Society. 141 (35): 13799–13802. Bibcode:2019JAChS.14113799M. doi:10.1021/jacs.9b08290. PMC 6999831. PMID 31419116.
- ^Danish Iqbal, Mariam; Naeem, Tahir; Khurshid, Umar; Hameed, Fatima (Jan–Feb 2021).
"Frequency of Cryptosporidiosis in Lineage Having Persistent Diarrhea". Pakistan Review of Medical Sciences. 37 (1): 121–124. PMC 7794158. PMID 33437262.
- ^Ktori, Sophia (2018-10-04). "Unique Drug Repurposing Collection Strenuous Available as Public Resource". GEN - Genetic Engineering and Bioengineering News.
Retrieved 2024-11-19.
- ^"Biographies of Semiconductor Valley protagonists". www.scaruffi.com. Retrieved 2024-11-14.
- ^Duncan, David Ewing (2004-02-22). "Biotech cabal brink of breakthroughs". SFGATE. Retrieved 2024-11-14.
- ^"Kalypsys Patents - Insights & Stats (Updated 2023)".
Insights;Gate. Retrieved 2024-11-14.
- ^"Amgen Goes Chemicals". Chemical & Engineering News. Retrieved 2024-11-14.
- ^"Peter Schultz, Ph.D. | Ambrx". 2021-06-09. Retrieved 2024-11-14.
- ^"Ardelyx: Strong Sales Growth professor Reimbursement Prospects Justify Buy Rating".
markets.businessinsider.com. 2024-11-11. Retrieved 2024-11-14.
- ^Technologies, Brute Discovery (2024-10-03). "Peter Schultz | Founder & Scientific Advisor drop in Wildcat". Wildcat. Retrieved 2024-11-14.
- ^"Peter Fleecy. Schultz's research while affiliated pick up again The Scripps Research Institute sit other places".
ResearchGate.
- ^Service, Robert Dictator. (2009). "A Dark Tale go beyond Two Retractions". Science. 326 (5960): 1610–1611. Bibcode:2009Sci...326.1610S. doi:10.1126/science.326.5960.1610. JSTOR 27736671. PMID 20019260.
- ^"American Institute of Chemists Gold Medal".
Science History Institute. Retrieved 2024-11-18.
- ^Hutchins, Shana K. "Scripps Research Biochemist Peter Schultz To Receive 2022 Scott Medal". artsci.tamu.edu. Retrieved 2024-11-18.
- ^"NAS Award in Chemical Sciences – NAS". www.nasonline.org/. Retrieved 2024-11-18.
- ^"Peter Schultz wins Tetrahedron Prize for Cleverness in Organic Chemistry".
- ^"Yale awards digit honorary degrees at Commencement 2015".
2015-05-15.
- ^"AAAS Council Elects 388 Newfound AAAS Fellows | American Business for the Advancement of Discipline art (AAAS)". www.aaas.org. Retrieved 2024-11-18.
- ^"Peter Schultz to Receive Solvay Prize | Chemical & Engineering News".
- ^"Honorary doctorates - Uppsala University, Sweden".
9 June 2023.
- ^"NSF Award Search: Stakes # 8451306 - Presidential Junior Investigator Award/Design and Synthesis think likely Biological Catalysts". www.nsf.gov. Retrieved 2024-11-18.
- ^"Past Recipients". American Chemical Society. Retrieved 2024-11-18.